The cost-effectiveness ratio is . . Compared to the untreated cohort,99907 yuan per lifer saving,8 yuan per life-year saving and 78 yuan per QALYs saving were accrued in the treated cohort.
详情正文
登录后查看完整内容
使用 DeepEvidence / 梅斯账号登录，新用户可在登录页面注册。
登录 / 注册登录成功后将返回当前页面，继续浏览。